188 related articles for article (PubMed ID: 15164877)
1. Nuclear factor-kappaB activation mediates cellular transformation, proliferation, invasion angiogenesis and metastasis of cancer.
Shishodia S; Aggarwal BB
Cancer Treat Res; 2004; 119():139-73. PubMed ID: 15164877
[No Abstract] [Full Text] [Related]
2. Nuclear factor-kappa B and cancer: its role in prevention and therapy.
Bharti AC; Aggarwal BB
Biochem Pharmacol; 2002 Sep; 64(5-6):883-8. PubMed ID: 12213582
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor-kappaB: the enemy within.
Aggarwal BB
Cancer Cell; 2004 Sep; 6(3):203-8. PubMed ID: 15380510
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor-kappaB activation: from bench to bedside.
Sethi G; Sung B; Aggarwal BB
Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB in solid tumors.
Pacifico F; Leonardi A
Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB as a therapeutic target in cancer.
Orlowski RZ; Baldwin AS
Trends Mol Med; 2002 Aug; 8(8):385-9. PubMed ID: 12127724
[TBL] [Abstract][Full Text] [Related]
7. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
Huang S; Pettaway CA; Uehara H; Bucana CD; Fidler IJ
Oncogene; 2001 Jul; 20(31):4188-97. PubMed ID: 11464285
[TBL] [Abstract][Full Text] [Related]
8. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
9. NF-kappaB and cancer: how intimate is this relationship.
Prasad S; Ravindran J; Aggarwal BB
Mol Cell Biochem; 2010 Mar; 336(1-2):25-37. PubMed ID: 19823771
[TBL] [Abstract][Full Text] [Related]
10. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer.
Romieu-Mourez R; Landesman-Bollag E; Seldin DC; Traish AM; Mercurio F; Sonenshein GE
Cancer Res; 2001 May; 61(9):3810-8. PubMed ID: 11325857
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8.
Karashima T; Sweeney P; Kamat A; Huang S; Kim SJ; Bar-Eli M; McConkey DJ; Dinney CP
Clin Cancer Res; 2003 Jul; 9(7):2786-97. PubMed ID: 12855659
[TBL] [Abstract][Full Text] [Related]
12. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.
Sunwoo JB; Chen Z; Dong G; Yeh N; Crowl Bancroft C; Sausville E; Adams J; Elliott P; Van Waes C
Clin Cancer Res; 2001 May; 7(5):1419-28. PubMed ID: 11350913
[TBL] [Abstract][Full Text] [Related]
13. Butein suppresses the expression of nuclear factor-kappa B-mediated matrix metalloproteinase-9 and vascular endothelial growth factor in prostate cancer cells.
Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
Toxicol In Vitro; 2010 Oct; 24(7):1927-34. PubMed ID: 20696233
[TBL] [Abstract][Full Text] [Related]
14. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
Allen CT; Ricker JL; Chen Z; Van Waes C
Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
[TBL] [Abstract][Full Text] [Related]
15. Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View.
Labbozzetta M; Notarbartolo M; Poma P
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32349210
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis and invasion by 3,3'-diindolylmethane is mediated by the nuclear factor-kappaB downstream target genes MMP-9 and uPA that regulated bioavailability of vascular endothelial growth factor in prostate cancer.
Kong D; Li Y; Wang Z; Banerjee S; Sarkar FH
Cancer Res; 2007 Apr; 67(7):3310-9. PubMed ID: 17409440
[TBL] [Abstract][Full Text] [Related]
17. Nobiletin Inhibits CD36-Dependent Tumor Angiogenesis, Migration, Invasion, and Sphere Formation Through the Cd36/Stat3/Nf-Κb Signaling Axis.
Sp N; Kang DY; Kim DH; Park JH; Lee HG; Kim HJ; Darvin P; Park YM; Yang YM
Nutrients; 2018 Jun; 10(6):. PubMed ID: 29914089
[TBL] [Abstract][Full Text] [Related]
18. NF-κB as a central regulator of macrophage function in tumors.
Biswas SK; Lewis CE
J Leukoc Biol; 2010 Nov; 88(5):877-84. PubMed ID: 20573802
[TBL] [Abstract][Full Text] [Related]
19. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer.
Nakada S; Kuboki S; Nojima H; Yoshitomi H; Furukawa K; Takayashiki T; Takano S; Miyazaki M; Ohtsuka M
Ann Surg Oncol; 2019 Mar; 26(3):907-917. PubMed ID: 30610554
[TBL] [Abstract][Full Text] [Related]
20. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
Holcomb B; Yip-Schneider M; Schmidt CM
Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]